Clinical Trials
26 trialsNCT04403022 2026-06-03
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Intuitive Surgical
Phase NA Active not recruiting
NCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT03693170 2026-05-29
ANCHOR-CRC
Pierre Fabre Medicament
Phase 2 Completed
NCT05185947 2026-05-29
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00159484 2026-05-28
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 1/2 Completed
NCT02134925 2026-05-28
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02965703 2026-05-28
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05064059 2026-05-26
MK-4280A-007
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03095781 2026-05-22
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
Phase 1 Completed
NCT05571293 2026-05-22
NEST-1
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT06540807 2026-05-20
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Phase NA Completed
NCT01150045 2026-05-19
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04406714 2026-05-15
SCORE
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT05056896 2026-05-15
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT06173375 2026-05-12
Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
Phase NA Completed
NCT00959647 2026-05-08
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Genentech, Inc.
Phase 2 Completed
NCT03797326 2026-05-04
LEAP-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT02837263 2026-05-01
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT05004350 2026-04-30
NAUTICALCRC
Pierre Fabre Medicament
Phase 2 Completed
NCT00819208 2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA Completed
NCT03981146 2026-04-22
ANICCA
University of Birmingham
Phase 2 Completed
NCT04355156 2026-04-16
AXMUS-C
Imperial College London
Phase 2 Completed
NCT03935282 2026-04-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
NCT02888743 2026-04-13
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04905082 2026-03-24
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Phase NA Active not recruiting
NCT06712901 2026-03-20
Social Media and Cancer Screening Information
University of Utah
Phase NA Completed